Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Immunomedics Inc
Immunomedics Inc
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Data gathering developments
As the use of RFID labelling spreads, the pharmaceutical industry is likely to see considerable benefits from this technology, says Richard Scott of SATO UK
The allogeneic revolution: reshaping the future of cell therapy
Moving from personalised, autologous treatments for individual patients toward scalable and accessible allogeneic therapies, the cell therapy field is undergoing a paradigm shift
SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme
Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development
Hovione and Zerion Pharma create joint venture to further expand the use of Dispersome technology
Hovione Farmaciência and Zerion Pharma have expanded their partnership to accelerate the development of the Dispersome technology platform and further expand its applicability...
Bioduro-Sundia launches new compound management center, strengthening drug discovery services
BioDuro-Sundia, a leading global contract research, development and manufacturing organisation (CRDMO), has announced the launch of a new Compound Management Center at its...
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Pharmaceutical
Johnson Matthey and Immunomedics join forces on cancer treatment
A strategic manufacturing partnership has been announced for key ingredient of FDA priority review candidate
Research & Development
Novel paths to treating rare diseases
Biotechnology is providing new pathways to treatments for many uncommon yet life-threatening diseases. Dr Sarah Houlton looks at some promising candidates
Subscribe now